Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
Open Access
- 14 August 2018
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 17 (1) , 1-12
Abstract
To improve outcomes in patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention remain an unmet clinical need. The study aimed to evaluate the efficacy and safety of G2-DESs and BP-DESs in patients with and without DM in a single center in China. A total of 7666 consecutive patients who exclusively had G2-DES or BP-DES implantation throughout 2013 in our center were studied. The primary efficacy endpoint was any target lesion revascularization (TLR), whereas the primary safety endpoint was a composite of death or myocardial infarction (MI) at 2-year follow-up. G2-DESs had a similar occurrence of death, non-fatal MI, TLR, stroke, and stent thrombosis compared with BP-DESs in patients with DM (all P > 0.05). The incidence of TVR and TLR was lower for G2-DESs than for BP-DESs in patients without DM (3.2% vs. 5.1%, P = 0.002; 2.2% vs. 4.5%, P < 0.001, respectively). Kaplan–Meier analysis also showed better TVR- and TLR-free survival rates for G2-DESs than for BP-DESs in patients without DM. Multivariate analysis showed that a BP-DES was an independent risk factor for TLR (hazard ratio 1.963, 95% confidence interval 1.390–2.772, P < 0.001) in patients without DM, which was not predictive of other components of major adverse cardiac events (P > 0.05). G2-DESs have better efficacy, represented by a reduced risk of TLR, and similar safety compared with BP-DESs in patients without DM. G2-DESs have similar efficacy and safety compared with BP-DESs in patients with DM at 2-year follow-up.Keywords
Funding Information
- National Foundation for Science and Technology support program of china (2016YFC1301300)
- National Science and technology support sub-project of program of china (2016YFC1301301)
- National Natural Science Foundation of China (81470486)
- National Natural Science Foundation for Young Scholars of China (81600292)
This publication has 44 references indexed in Scilit:
- The Association of Diabetes Mellitus with Clinical Outcomes after Coronary Stenting: A Meta-AnalysisPLOS ONE, 2013
- Clinical Impact of Second-Generation Everolimus-Eluting Stent Compared With First-Generation Drug-Eluting Stents in Diabetes Mellitus PatientsJACC: Cardiovascular Interventions, 2012
- Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent ImplantationCirculation, 2012
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Advantages and disadvantages of biodegradable platforms in drug eluting stentsWorld Journal of Cardiology, 2011
- Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)The American Journal of Cardiology, 2010
- Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarctionEuropean Heart Journal, 2007
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic PatientsCirculation, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004